Recent research demonstrate the potential of RMP1-14, a recently created anti-mouse PD-1 reagent , for enhancing cancer immunotherapy . Unlike conventional approaches, RMP1-14 exhibits increased binding to https://dirstop.com/story28116265/harnessing-rmp1-14-an-new-anti-mouse-pd1-agent-in-immune-therapy